Silva Manzano Daniel Adriano 13D and 13G filings for Neoleukin Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:06 pm Sale | 2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | Silva Manzano Daniel Adriano | 145,458 6.800% | -1,449 (-0.99%) | Filing |
| 2021-02-12 4:25 pm Sale | 2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | Silva Manzano Daniel Adriano | 146,907 6.960% | -8,688 (-5.58%) | Filing |